Skip to content
SEKISUI XenoTech DD Blog Logo

Drug Development Blog

Commentary to provide context and explain significance of research is sometimes just as important as the research itself. That’s why our experts make it a priority to provide you with helpful content distilled from the many years of experience our team has accumulated. The Drug Development Insights blog contains overviews and deep dives into the drug metabolism and pharmacokinetics topics you care about—regulatory expectations, risk assessment, safety considerations, scientific innovation, study design elements, interpretation of results, and more. Explore our entries chronologically or by category to get insight into the many pieces of your drug’s development.

DDI & Drug Repurposing Article featured in Drug Discovery World (DDW) Spring Edition 2021

Repurposing (repositioning, re-profiling, or re-tasking) a drug potentially saves years of costly testing from going to waste and potentially providing a higher chance of success. “Perhaps most importantly, the risk of failure is lower […] because the repurposed drug has already been found to be sufficiently safe in preclinical models and humans if early-stage trials have been completed...

SEKISUI again honored for its ESG management

Every year, the S&P Global Sustainability Yearbook delivers one of the world’s most comprehensive and independent analysis on corporate sustainability. In 2021,...

Meet the Scientist: Stephanie Helmstetter

As part of our Meet the Scientist series, we introduce you to one of our most notable product experts, Stephanie Helmstetter.

Interview with Outsourcing Pharma: Repurposing existing drugs accelerates discovery

“Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an...

Meet the Scientist: Lois Haupt

As part of our Meet the Scientist series, we introduce you to one of our most notable Enzyme Inhibition experts, Lois Haupt.

Updated Look & Fresh Features: Welcome to Our Brand New Website!

We are thrilled to welcome you to the brand new SEKISUI XenoTech website! The reconstruction project is a massive overhaul of over 1,000 pages carefully…

Drug-Drug Interaction (DDI) Prediction Models Following In Vitro Studies in Preclinical Development

In preclinical development, a drug will be evaluated for potential to cause a drug-drug interaction (DDI) using in vitro experiments and then calculations that...

Toxicokinetic (TK) Analysis for Preclinical Drug Development

The main goal of preclinical toxicokinetic (TK) studies is to establish a correlation between a candidate compound’s concentration or dose...

SEKISUI XenoTech Named Most Innovative Drug Development Solutions Provider – USA 2020

The 2020 Technology Innovator Awards returns for its fifth year “to reward those talented and dedicated individuals and firms working...

Who is SEKISUI America?

We pride ourselves on providing cutting edge science for the betterment of humankind, but we’re not the only one. SEKISUI...

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate